A	a	DT	O
crucial	crucial	JJ	O
physiological	physiological	JJ	O
reaction	reaction	NN	O
for	for	IN	O
the	the	DT	O
survival	survival	NN	O
of	of	IN	O
all	all	DT	O
living	live	VBG	O
organisms	organism	NNS	O
is	be	VBZ	O
the	the	DT	O
pivotal	pivotal	JJ	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
/	/	SYM	O
dehydration	dehydration	NN	O
of	of	IN	O
the	the	DT	O
central	central	JJ	O
metabolism	metabolism	NN	O
.	.	.	O

This	this	DT	O
reaction	reaction	NN	O
is	be	VBZ	O
connected	connect	VBN	O
with	with	IN	O
numerous	numerous	JJ	O
metabolic	metabolic	JJ	O
pathways	pathway	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
photosynthesis	photosynthesis	NN	O
and	and	CC	O
carboxylation	carboxylation	NN	O
reactions	reaction	NNS	O
,	,	,	O
and	and	CC	O
biochemical	biochemical	JJ	O
pathways	pathway	NNS	O
including	include	VBG	O
pH	pH	NNP	O
homeostasis	homeostasis	NN	O
,	,	,	O
secretion	secretion	NN	O
of	of	IN	O
electrolytes	electrolyte	NNS	O
,	,	,	O
transport	transport	NN	O
of	of	IN	O
CO2	CO2	NNP	O
and	and	CC	O
bicarbonate	bicarbonate	NN	O
,	,	,	O
and	and	CC	O
so	so	RB	O
on	on	IN	B
,	,	,	B
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
the	the	DT	O
interconversion	interconversion	NN	O
of	of	IN	O
CO2	CO2	NNP	O
and	and	CC	O
HCO3â	hco3â	NN	O
is	be	VBZ	O
spontaneously	spontaneously	RB	O
and	and	CC	O
precisely	precisely	RB	O
balanced	balanced	JJ	O
form	form	NN	O
the	the	DT	O
living	live	VBG	O
organisms	organism	NNS	O
to	to	TO	O
maintain	maintain	VB	O
the	the	DT	O
equilibrium	equilibrium	NN	O
between	between	IN	O
dissolved	dissolve	VBN	O
inorganic	inorganic	JJ	O
carbon	carbon	NN	O
dioxide	dioxide	NN	O
,	,	,	O
carbonic	carbonic	JJ	O
acid	acid	NN	O
,	,	,	O
bicarbonate	bicarbonate	NNP	O
HCO3â	HCO3â	NNP	O
and	and	CC	O
carbonate	carbonate	VB	O
CO32â	CO32â	NNP	O
)	)	-RRB-	B
.	.	.	O

The	the	DT	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
/	/	SYM	O
dehydration	dehydration	NN	O
is	be	VBZ	O
catalysed	catalyse	VBN	O
by	by	IN	O
a	a	DT	O
superfamily	superfamily	NN	O
of	of	IN	O
metalloenzymes	metalloenzymes	NNP	O
,	,	,	O
known	know	VBN	O
as	as	IN	O
carbonic	carbonic	JJ	O
anhydrases	anhydrase	NNS	B
,	,	,	O
which	which	WDT	O
are	be	VBP	O
categorised	categorise	VBN	O
into	into	IN	O
eight	eight	CD	O
genetically	genetically	RB	O
distinct	distinct	JJ	O
families	family	NNS	O
,	,	,	O
named	name	VBN	O
with	with	IN	O
the	the	DT	O
Greek	greek	JJ	O
letters	letter	NNS	O
:	:	:	O
Î±	î±	NN	O
,	,	,	O
Î²	î²	NN	O
,	,	,	O
Î³	î³	NN	O
,	,	,	O
Î	Î	NNP	O
´	´	NNP	O
,	,	,	O
Î¶	Î¶	NNP	O
,	,	,	O
Î	Î	NNP	O
·	·	NFP	O
,	,	,	O
Éµ	éµ	UH	O
,	,	,	O
and	and	CC	O
Î¹.	Î¹.	NNP	O
The	the	DT	O
last	last	JJ	O
three	three	CD	O
classes	class	NNS	O
were	be	VBD	O
recently	recently	RB	O
discovered	discover	VBN	B
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
members	member	NNS	O
of	of	IN	O
each	each	DT	O
class	class	NN	O
possess	possess	VBP	O
multiple	multiple	JJ	O
transcript	transcript	NN	O
variants	variant	NNS	O
and	and	CC	O
protein	protein	NN	O
isoforms	isoform	NNS	O
,	,	,	O
which	which	WDT	O
are	be	VBP	O
characterised	characterise	VBN	O
by	by	IN	O
different	different	JJ	O
biochemical	biochemical	JJ	O
properties	property	NNS	O
and	and	CC	O
have	have	VBP	O
specific	specific	JJ	O
tissue	tissue	NN	O
/	/	SYM	O
organ	organ	NN	O
and	and	CC	O
sub	sub	JJ	O
-	-	JJ	O
cellular	cellular	JJ	O
localizations	localization	NNS	B
,	,	,	B
.	.	.	O

CAs	ca	NNS	O
present	present	JJ	O
in	in	IN	O
animals	animal	NNS	O
belong	belong	VBP	O
to	to	IN	O
Î±-class	î±-class	NN	B
,	,	,	B
,	,	,	O
plants	plant	NNS	O
and	and	CC	O
algae	algae	NN	O
have	have	VBP	O
Î±-	Î±-	NNP	O
,	,	,	O
Î²-	î²-	UH	O
,	,	,	O
Î³-	î³-	UH	O
,	,	,	O
Î´-	Î´-	NNP	O
Î¸-	Î¸-	NNP	O
and	and	CC	O
Î¹-classes	î¹-classe	NNS	O
;	;	:	O
fungi	fungi	NNP	O
encode	encode	VBP	O
for	for	IN	O
Î±-	Î±-	NNP	O
and	and	CC	O
Î²-CAs	î²-cas	JJ	O
;	;	,	O
protozoa	protozoa	JJ	O
for	for	IN	O
Î±-	Î±-	NNP	O
,	,	,	O
Î²-	î²-	NN	O
and/or	and/or	CC	O
Î·-CAs	Î·-CAs	NFP	O
;	;	:	O
bacteria	bacteria	NNS	O
for	for	IN	O
Î±-	Î±-	NNP	O
,	,	,	O
Î²-	î²-	UH	O
,	,	,	O
Î³-	î³-	NN	O
and	and	CC	O
Î¹-CA	Î¹-CA	JJR	O
classes	class	NNS	B
,	,	,	B
,	,	,	B
.	.	.	O

Besides	besides	RB	O
,	,	,	O
a	a	DT	O
matrix	matrix	NN	O
protein	protein	NN	O
called	call	VBN	O
nacrein	nacrein	NNP	O
has	have	VBZ	O
been	be	VBN	O
identified	identify	VBN	O
in	in	IN	O
the	the	DT	O
oyster	oyster	JJ	O
Pinctada	Pinctada	NNP	O
fucata	fucata	NN	O
.	.	.	O

It	-PRON-	PRP	O
participates	participate	VBZ	O
in	in	IN	O
the	the	DT	O
formation	formation	NN	O
of	of	IN	O
the	the	DT	O
nacreous	nacreous	JJ	O
layer	layer	NN	O
and	and	CC	O
is	be	VBZ	O
characterised	characterise	VBN	O
by	by	IN	O
a	a	DT	O
CA	CA	NNP	O
domain	domain	NN	O
present	present	JJ	O
at	at	IN	O
the	the	DT	O
N	N	NNP	O
-	-	HYPH	O
terminus	terminus	NN	O
part	part	NN	O
of	of	IN	O
the	the	DT	O
polypeptide	polypeptide	NN	O
sequence	sequence	NN	B
.	.	.	O

In	in	IN	O
mammals	mammal	NNS	O
,	,	,	O
16	16	CD	O
Î±-CA	Î±-CA	NNP	O
isoforms	isoform	NNS	O
have	have	VBP	O
been	be	VBN	O
identified	identify	VBN	O
:	:	:	O
five	five	CD	O
of	of	IN	O
them	-PRON-	PRP	O
are	be	VBP	O
cytosolic	cytosolic	JJ	O
,	,	,	O
five	five	CD	O
are	be	VBP	O
membrane	membrane	NN	O
-	-	HYPH	O
bound	bind	VBN	O
,	,	,	O
two	two	CD	O
are	be	VBP	O
mitochondrial	mitochondrial	NN	O
,	,	,	O
and	and	CC	O
only	only	RB	O
one	one	CD	O
is	be	VBZ	O
secreted	secrete	VBN	O
,	,	,	O
the	the	DT	O
last	last	JJ	O
three	three	CD	O
being	be	VBG	O
devoid	devoid	JJ	O
of	of	IN	O
catalytic	catalytic	JJ	O
activity	activity	NN	O
and	and	CC	O
referred	refer	VBD	O
to	to	IN	O
as	as	IN	O
CA	CA	NNP	O
Related	Related	NNP	O
Proteins	Proteins	NNPS	B
,	,	,	B
,	,	,	B
.	.	.	O

CA	ca	NN	O
active	active	JJ	O
site	site	NN	O
includes	include	VBZ	O
a	a	DT	O
zinc	zinc	NN	O
ion	ion	NN	O
,	,	,	O
which	which	WDT	O
plays	play	VBZ	O
a	a	DT	O
critical	critical	JJ	O
role	role	NN	O
in	in	IN	O
the	the	DT	O
catalytic	catalytic	JJ	O
enzyme	enzyme	NNS	O
function	function	NN	O
.	.	.	O

In	in	IN	O
addition	addition	NN	O
to	to	IN	O
the	the	DT	O
zinc	zinc	NN	O
,	,	,	O
Î¶-and	Î¶-and	NNP	O
Î³-CAs	Î³-CAs	NNP	O
reflect	reflect	VBP	O
exceptions	exception	NNS	O
to	to	IN	O
this	this	DT	O
principle	principle	NN	O
since	since	IN	O
they	-PRON-	PRP	O
can	can	MD	O
use	use	VB	O
cadmium	cadmium	NN	O
Î¶	Î¶	NNP	O
,	,	,	O
iron	iron	NN	O
,	,	,	O
or	or	CC	O
cobalt	cobalt	NN	B
,	,	,	B
.	.	.	O

The	the	DT	O
glycolytic	glycolytic	JJ	O
metabolism	metabolism	NN	O
of	of	IN	O
cancer	cancer	NN	O
was	be	VBD	O
evaluated	evaluate	VBN	O
for	for	IN	O
so	so	RB	O
many	many	JJ	O
years	year	NNS	O
to	to	TO	O
describe	describe	VB	O
the	the	DT	O
fundamental	fundamental	JJ	O
role	role	NN	O
of	of	IN	O
tumour	tumour	NN	O
microenvironment	microenvironment	NN	O
and	and	CC	O
glycolysis	glycolysis	NN	O
in	in	IN	O
cancer	cancer	NN	O
growth	growth	NN	O
and	and	CC	O
progression	progression	NN	B
.	.	.	O

The	the	DT	O
transcription	transcription	NN	O
factors	factor	NNS	O
of	of	IN	O
the	the	DT	O
glycolytic	glycolytic	JJ	O
pathway	pathway	NN	O
affect	affect	VBP	O
cell	cell	NN	O
proliferation	proliferation	NN	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
an	an	DT	O
essential	essential	JJ	O
feature	feature	NN	O
of	of	IN	O
carcinogenesis	carcinogenesis	NN	B
.	.	.	O

Different	different	JJ	O
types	type	NNS	O
of	of	IN	O
enzymes	enzyme	NNS	O
are	be	VBP	O
produced	produce	VBN	O
by	by	IN	O
tumours	tumour	NNS	O
or	or	CC	O
by	by	IN	O
the	the	DT	O
body	body	NN	O
in	in	IN	O
response	response	NN	O
to	to	IN	O
malignancy	malignancy	NN	O
and	and	CC	O
used	use	VBD	O
as	as	IN	O
cancer	cancer	NN	O
biomarkers	biomarker	NNS	B
.	.	.	O

It	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
shown	show	VBN	O
that	that	IN	O
the	the	DT	O
expression	expression	NN	O
levels	level	NNS	O
of	of	IN	O
certain	certain	JJ	O
enzymes	enzyme	NNS	O
can	can	MD	O
vary	vary	VB	O
in	in	IN	O
various	various	JJ	O
types	type	NNS	O
of	of	IN	O
cancer	cancer	NN	B
.	.	.	O

CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
a	a	DT	O
transmembrane	transmembrane	JJ	O
CA	CA	NNP	O
isoform	isoform	NN	O
expressed	express	VBN	O
in	in	IN	O
healthy	healthy	JJ	O
tissues	tissue	NNS	O
.	.	.	O

Figure	figure	NN	O
1	1	CD	O
shows	show	VBZ	O
the	the	DT	O
catalytically	catalytically	RB	O
active	active	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
on	on	IN	O
the	the	DT	O
cellular	cellular	JJ	O
membrane	membrane	NN	O
surface	surface	NN	B
.	.	.	O

CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
highly	highly	RB	O
overexpressed	overexpresse	VBN	O
in	in	IN	O
many	many	JJ	O
types	type	NNS	O
of	of	IN	O
cancer	cancer	NN	B
,	,	,	B
.	.	.	O

For	for	IN	O
example	example	NN	O
,	,	,	O
its	-PRON-	PRP$	O
expression	expression	NN	O
is	be	VBZ	O
increased	increase	VBN	O
considerably	considerably	RB	O
in	in	IN	O
solid	solid	JJ	O
tumours	tumour	NNS	O
of	of	IN	O
uterus	uterus	NN	O
,	,	,	O
kidney	kidney	NN	O
,	,	,	O
lung	lung	NN	O
,	,	,	O
colon	colon	NN	O
,	,	,	O
breast	breast	NN	O
,	,	,	O
brain	brain	NN	O
,	,	,	O
and	and	CC	O
ovary	ovary	JJ	B
.	.	.	O

Tumour	tumour	NN	O
cells	cell	NNS	O
decrease	decrease	VBP	O
their	-PRON-	PRP$	O
extracellular	extracellular	JJ	O
pH	ph	NN	O
by	by	IN	O
lactic	lactic	JJ	O
acid	acid	NN	O
production	production	NN	O
and	and	CC	O
CO2	CO2	NNP	O
hydration	hydration	NN	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
catalysed	catalyse	VBN	O
by	by	IN	O
CAs	ca	NNS	O
.	.	.	O

Since	since	IN	O
the	the	DT	O
tumour	tumour	NN	O
-	-	HYPH	O
associated	associate	VBN	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
an	an	DT	O
efficient	efficient	JJ	O
catalyst	catalyst	NN	O
for	for	IN	O
the	the	DT	O
conversion	conversion	NN	O
of	of	IN	O
CO2	CO2	NNP	O
in	in	IN	O
bicarbonate	bicarbonate	NN	O
and	and	CC	O
protons	proton	NNS	O
,	,	,	O
they	-PRON-	PRP	O
contribute	contribute	VBP	O
to	to	IN	O
the	the	DT	O
acidification	acidification	NN	O
of	of	IN	O
the	the	DT	O
tumour	tumour	NN	O
environment	environment	NN	O
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
its	-PRON-	PRP$	O
activity	activity	NN	O
leads	lead	VBZ	O
to	to	IN	O
the	the	DT	O
acquisition	acquisition	NN	O
of	of	IN	O
metastatic	metastatic	JJ	O
phenotypes	phenotype	NNS	O
and	and	CC	O
chemoresistance	chemoresistance	NN	O
to	to	IN	O
weakly	weakly	JJ	O
basic	basic	JJ	O
anticancer	anticancer	NN	O
drugs	drug	NNS	B
.	.	.	O

Structure	structure	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
isoenzyme	isoenzyme	NNS	O
.	.	.	O

.pH	.pH	NNP	O
regulation	regulation	NN	O
of	of	IN	O
carbonic	carbonic	JJ	O
anhydrase	anhydrase	NN	O
enzymes	enzyme	NNS	O
in	in	IN	O
tumour	tumour	NN	O
cells	cell	NNS	O
.	.	.	O

Interestingly	interestingly	RB	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
has	have	VBZ	O
a	a	DT	O
metastatic	metastatic	JJ	O
activity	activity	NN	O
related	relate	VBN	O
to	to	IN	O
the	the	DT	O
extracellular	extracellular	JJ	O
acidity	acidity	NN	O
since	since	IN	O
it	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
shown	show	VBN	O
to	to	TO	O
promote	promote	VB	O
migration	migration	NN	O
and	and	CC	O
invasion	invasion	NN	O
in	in	IN	O
tumour	tumour	NN	O
cells	cell	NNS	B
,	,	,	B
.	.	.	O

Furthermore	furthermore	RB	O
,	,	,	O
oxygen	oxygen	NN	O
has	have	VBZ	O
a	a	DT	O
crucial	crucial	JJ	O
function	function	NN	O
in	in	IN	O
the	the	DT	O
regulation	regulation	NN	O
of	of	IN	O
redox	redox	NN	O
balance	balance	NN	O
and	and	CC	O
energy	energy	NN	O
production	production	NN	O
in	in	IN	O
tumour	tumour	NN	O
tissues	tissue	NNS	O
.	.	.	O

An	an	DT	O
inadequate	inadequate	JJ	O
amount	amount	NN	O
of	of	IN	O
oxygen	oxygen	NN	O
in	in	IN	O
the	the	DT	O
tissues	tissues	NNP	O
causes	cause	VBZ	O
hypoxia	hypoxia	NNP	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
a	a	DT	O
characteristic	characteristic	JJ	O
marker	marker	NN	O
of	of	IN	O
the	the	DT	O
tumour	tumour	NN	O
microenvironment	microenvironment	NN	O
.	.	.	O

Hypoxia	Hypoxia	NNP	O
regulates	regulate	VBZ	O
the	the	DT	O
expression	expression	NN	O
of	of	IN	O
many	many	JJ	O
genes	gene	NNS	O
inducing	induce	VBG	O
a	a	DT	O
phenotypic	phenotypic	JJ	O
alteration	alteration	NN	O
of	of	IN	O
stromal	stromal	JJ	O
cells	cell	NNS	O
in	in	IN	O
the	the	DT	O
tumour	tumour	NN	O
microenvironment	microenvironment	NN	O
and	and	CC	O
promoting	promote	VBG	O
the	the	DT	O
survival	survival	NN	O
of	of	IN	O
cancer	cancer	NN	O
cells	cell	NNS	O
.	.	.	O

Low	low	JJ	O
oxygen	oxygen	NN	O
activates	activate	VBZ	O
the	the	DT	O
HIF-1	HIF-1	NNP	O
,	,	,	O
the	the	DT	O
hypoxia	hypoxia	NN	O
-	-	HYPH	O
inducible	inducible	JJ	O
factor	factor	NN	O
1	1	CD	B
,	,	,	B
,	,	,	O
which	which	WDT	O
starts	start	VBZ	O
the	the	DT	O
transcription	transcription	NN	O
of	of	IN	O
several	several	JJ	O
hypoxia	hypoxia	NN	O
-	-	HYPH	O
inducible	inducible	JJ	O
genes	gene	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
Vascular	Vascular	NNP	O
Endothelial	Endothelial	NNP	O
Growth	Growth	NNP	O
Factor	Factor	NNP	O
,	,	,	O
Glucose	Glucose	NNP	O
Transporter	Transporter	NNP	O
1	1	CD	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
and	and	CC	O
CA	CA	NNP	O
XII	XII	NNP	O
)	)	-RRB-	B
.	.	.	O

CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
one	one	CD	O
of	of	IN	O
the	the	DT	O
most	most	RBS	O
potent	potent	JJ	O
hypoxia	hypoxia	NN	O
-	-	HYPH	O
induced	induce	VBN	O
proteins	protein	NNS	O
,	,	,	O
and	and	CC	O
the	the	DT	O
hypoxia	hypoxia	NN	O
-	-	HYPH	O
inducible	inducible	JJ	O
proteins	protein	NNS	O
are	be	VBP	O
important	important	JJ	O
anti	anti	JJ	O
-	-	JJ	O
cancer	cancer	JJ	O
targets	target	NNS	B
.	.	.	O

As	as	IN	O
a	a	DT	O
result	result	NN	O
,	,	,	O
it	-PRON-	PRP	O
is	be	VBZ	O
readily	readily	RB	O
apparent	apparent	JJ	O
that	that	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
associated	associate	VBN	O
with	with	IN	O
many	many	JJ	O
tumours	tumour	NNS	O
and	and	CC	O
are	be	VBP	O
involved	involve	VBN	O
in	in	IN	O
the	the	DT	O
cancer	cancer	NN	O
process	process	NN	B
.	.	.	O

The	the	DT	O
specific	specific	JJ	O
inhibition	inhibition	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
activity	activity	NN	O
with	with	IN	O
selective	selective	JJ	O
inhibitors	inhibitor	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
sulphonamide	sulphonamide	JJ	O
derivatives	derivative	NNS	O
,	,	,	O
represents	represent	VBZ	O
a	a	DT	O
good	good	JJ	O
strategy	strategy	NN	O
for	for	IN	O
establishing	establish	VBG	O
the	the	DT	O
driving	drive	VBG	O
role	role	NN	O
of	of	IN	O
this	this	DT	O
isoform	isoform	NN	O
,	,	,	O
as	as	RB	O
well	well	RB	O
as	as	IN	O
other	other	JJ	O
CAs	CAs	NNP	O
,	,	,	O
for	for	IN	O
example	example	NN	O
,	,	,	O
CA	CA	NNP	O
XII	XII	NNP	O
,	,	,	O
in	in	IN	O
tumorigenesis	tumorigenesis	NN	B
.	.	.	O

Many	many	JJ	O
CA	CA	NNP	O
inhibitors	inhibitor	NNS	O
exist	exist	VBP	O
,	,	,	O
which	which	WDT	O
could	could	MD	O
be	be	VB	O
classified	classify	VBN	O
as	as	IN	O
inhibitors	inhibitor	NNS	O
binding	bind	VBG	O
the	the	DT	O
metal	metal	NN	O
ion	ion	NN	O
,	,	,	O
inhibitors	inhibitor	NNS	O
anchoring	anchor	VBG	O
to	to	IN	O
the	the	DT	O
water	water	NN	O
molecule	molecule	VB	O
/	/	SYM	O
hydroxide	hydroxide	NN	O
ion	ion	NN	O
coordinated	coordinate	VBN	O
to	to	IN	O
the	the	DT	O
metal	metal	NN	O
,	,	,	O
inhibitors	inhibitor	NNS	O
occluding	occlude	VBG	O
the	the	DT	O
active	active	JJ	O
site	site	NN	O
entrance	entrance	NN	O
and	and	CC	O
inhibitors	inhibitor	NNS	O
linking	link	VBG	O
out	out	IN	O
of	of	IN	O
the	the	DT	O
active	active	JJ	O
site	site	NN	B
.	.	.	O

Many	many	JJ	O
of	of	IN	O
these	these	DT	O
inhibitors	inhibitor	NNS	O
can	can	MD	O
be	be	VB	O
used	use	VBN	O
to	to	TO	O
reduce	reduce	VB	O
the	the	DT	O
proliferation	proliferation	NN	O
and	and	CC	O
invasion	invasion	NN	O
capacity	capacity	NN	O
of	of	IN	O
cancer	cancer	NN	O
cells	cell	NNS	B
.	.	.	O

Since	since	IN	O
pH	ph	RB	O
-	-	HYPH	O
related	relate	VBN	O
cancer	cancer	NN	O
growth	growth	NN	O
and	and	CC	O
metastasis	metastasis	NN	O
might	may	MD	O
be	be	VB	O
dependent	dependent	JJ	O
on	on	IN	O
the	the	DT	O
enzyme	enzyme	NNS	O
activity	activity	NN	O
of	of	IN	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
isoform	isoform	NN	O
,	,	,	O
the	the	DT	O
identification	identification	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
as	as	IN	O
tumour	tumour	NN	O
biomarker	biomarker	NN	O
in	in	IN	O
the	the	DT	O
liquid	liquid	JJ	O
biopsy	biopsy	NN	O
is	be	VBZ	O
crucial	crucial	JJ	O
for	for	IN	O
a	a	DT	O
new	new	JJ	O
approach	approach	NN	O
concerning	concern	VBG	O
the	the	DT	O
treatment	treatment	NN	O
of	of	IN	O
malignancy	malignancy	NN	O
.	.	.	O

The	the	DT	O
role	role	NN	O
of	of	IN	O
cancer	cancer	NN	O
markers	marker	NNS	O
in	in	IN	O
carcinogenesis	carcinogenesis	NN	O
is	be	VBZ	O
pivotal	pivotal	JJ	O
for	for	IN	O
early	early	JJ	O
diagnosis	diagnosis	NN	O
,	,	,	O
promotion	promotion	NN	O
of	of	IN	O
suitable	suitable	JJ	O
procedures	procedure	NNS	O
,	,	,	O
and	and	CC	O
leading	lead	VBG	O
right	right	JJ	O
management	management	NN	O
strategies	strategy	NNS	B
.	.	.	O

Recently	recently	RB	O
,	,	,	O
liquid	liquid	JJ	O
biopsy	biopsy	NN	O
has	have	VBZ	O
begun	begin	VBN	O
an	an	DT	O
exciting	exciting	JJ	O
approach	approach	NN	O
in	in	IN	O
terms	term	NNS	O
of	of	IN	O
early	early	JJ	O
detection	detection	NN	O
of	of	IN	O
tumor	tumor	NN	B
,	,	,	B
.	.	.	O

The	the	DT	O
technique	technique	NN	O
,	,	,	O
starting	start	VBG	O
from	from	IN	O
the	the	DT	O
blood	blood	NN	O
or	or	CC	O
body	body	NN	O
fluids	fluid	NNS	O
,	,	,	O
isolates	isolate	VBZ	O
tumour	tumour	NN	O
-	-	HYPH	O
derived	derive	VBN	O
components	component	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
circulating	circulate	VBG	O
tumour	tumour	NN	O
cells	cell	NNS	O
,	,	,	O
circulating	circulate	VBG	O
tumour	tumour	NN	O
DNA	dna	NN	O
,	,	,	O
and	and	CC	O
extracellular	extracellular	JJ	O
vesicles	vesicle	NNS	O
,	,	,	O
as	as	IN	O
a	a	DT	O
source	source	NN	O
of	of	IN	O
genomic	genomic	JJ	O
and	and	CC	O
proteomic	proteomic	JJ	O
information	information	NN	O
in	in	IN	O
patients	patient	NNS	O
with	with	IN	O
cancer	cancer	NN	B
.	.	.	O

Liquid	liquid	JJ	O
biopsy	biopsy	NN	O
is	be	VBZ	O
an	an	DT	O
appropriate	appropriate	JJ	O
technique	technique	NN	O
for	for	IN	O
correct	correct	JJ	O
treatments	treatment	NNS	O
and	and	CC	O
figuring	figure	VBG	O
out	out	RP	O
the	the	DT	O
genetic	genetic	JJ	O
changes	change	NNS	O
in	in	IN	O
the	the	DT	O
tumour	tumour	NN	O
.	.	.	O

It	-PRON-	PRP	O
can	can	MD	O
be	be	VB	O
applied	apply	VBN	O
to	to	IN	O
many	many	JJ	O
types	type	NNS	O
of	of	IN	O
cancer	cancer	NN	O
,	,	,	O
analysing	analyse	VBG	O
the	the	DT	O
blood	blood	NN	O
or	or	CC	O
body	body	NN	O
fluids	fluid	NNS	O
of	of	IN	O
the	the	DT	O
patient	patient	NN	O
taken	take	VBN	O
in	in	IN	O
a	a	DT	O
non	non	JJ	O
-	-	JJ	O
invasive	invasive	JJ	O
manner	manner	NN	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
biopsy	biopsy	NN	O
and	and	CC	O
without	without	IN	O
even	even	RB	O
detecting	detect	VBG	O
the	the	DT	O
symptoms	symptom	NNS	B
.	.	.	O

Thomas	Thomas	NNP	O
Ashworth	Ashworth	NNP	O
investigated	investigate	VBD	O
CTCs	ctc	NNS	O
in	in	IN	O
the	the	DT	O
1860s	1860	NNS	O
,	,	,	O
considering	consider	VBG	O
that	that	IN	O
tumour	tumour	NN	O
cells	cell	NNS	O
could	could	MD	O
have	have	VB	O
crossed	cross	VBN	O
the	the	DT	O
vessel	vessel	NN	O
wall	wall	NN	O
and	and	CC	O
enter	enter	VB	O
the	the	DT	O
bloodstream	bloodstream	NN	B
.	.	.	O

These	these	DT	O
cells	cell	NNS	O
are	be	VBP	O
released	release	VBN	O
from	from	IN	O
primary	primary	JJ	O
or	or	CC	O
metastatic	metastatic	JJ	O
cells	cell	NNS	O
.	.	.	O

A	a	DT	O
few	few	JJ	O
steps	step	NNS	O
are	be	VBP	O
required	require	VBN	O
for	for	IN	O
the	the	DT	O
metastatic	metastatic	JJ	O
process	process	NN	O
.	.	.	O

First	first	RB	O
,	,	,	O
CTCs	ctc	NNS	O
are	be	VBP	O
separated	separate	VBN	O
from	from	IN	O
the	the	DT	O
tumour	tumour	NN	O
and	and	CC	O
incorporated	incorporate	VBD	O
into	into	IN	O
the	the	DT	O
bloodstream	bloodstream	NN	O
.	.	.	O

The	the	DT	O
circulating	circulate	VBG	O
CTCs	ctc	NNS	O
are	be	VBP	O
then	then	RB	O
protected	protect	VBN	O
from	from	IN	O
the	the	DT	O
immune	immune	JJ	O
cells	cell	NNS	O
to	to	TO	O
perform	perform	VB	O
extravasation	extravasation	NN	O
.	.	.	O

After	after	IN	O
that	that	DT	O
,	,	,	O
these	these	DT	O
cells	cell	NNS	O
adapt	adapt	VBP	O
to	to	IN	O
the	the	DT	O
microenvironment	microenvironment	NN	O
of	of	IN	O
the	the	DT	O
new	new	JJ	O
tissue	tissue	NN	O
and	and	CC	O
to	to	TO	O
form	form	VB	O
metastatic	metastatic	JJ	O
lesions	lesion	NNS	O
.	.	.	O

CTCs	ctc	NNS	O
are	be	VBP	O
found	find	VBN	O
in	in	IN	O
circulation	circulation	NN	O
as	as	IN	O
single	single	JJ	O
CTCs	ctc	NNS	O
or	or	CC	O
CTC	CTC	NNP	O
clusters	cluster	NNS	O
.	.	.	O

In	in	IN	O
the	the	DT	O
literature	literature	NN	O
,	,	,	O
it	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
reported	report	VBN	O
that	that	IN	O
tumour	tumour	NN	O
progression	progression	NN	O
and	and	CC	O
patient	patient	JJ	O
survival	survival	NN	O
is	be	VBZ	O
correlated	correlate	VBN	O
with	with	IN	O
the	the	DT	O
numbers	number	NNS	O
of	of	IN	O
CTCs	ctc	NNS	B
.	.	.	O

The	the	DT	O
cont	cont	NN	O
of	of	IN	O
CTCs	ctc	NNS	O
is	be	VBZ	O
also	also	RB	O
useful	useful	JJ	O
in	in	IN	O
the	the	DT	O
treatment	treatment	NN	O
response	response	NN	O
process	process	NN	O
.	.	.	O

The	the	DT	O
technics	technic	NNS	O
known	know	VBN	O
as	as	IN	O
immunophenotypic	immunophenotypic	JJ	O
identification	identification	NN	O
of	of	IN	O
cytokeratin	cytokeratin	NN	O
,	,	,	O
enzymatic	enzymatic	JJ	O
methods	method	NNS	O
,	,	,	O
and	and	CC	O
RT	RT	NNP	O
-	-	HYPH	O
qPCR	qPCR	NNP	O
are	be	VBP	O
used	use	VBN	O
to	to	TO	O
detect	detect	VB	O
CTCs	ctc	NNS	B
.	.	.	O

The	the	DT	O
cell	cell	NN	O
surface	surface	NN	O
glycoprotein	glycoprotein	NN	O
,	,	,	O
EPCAM	EPCAM	NNP	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
highly	highly	RB	O
expressed	express	VBN	O
in	in	IN	O
epithelial	epithelial	JJ	O
cancer	cancer	NN	O
cells	cell	NNS	O
,	,	,	O
serves	serve	VBZ	O
as	as	IN	O
the	the	DT	O
primary	primary	JJ	O
antigen	antigen	NN	O
for	for	IN	O
CTCs	ctc	NNS	O
detection	detection	NN	O
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
with	with	IN	O
this	this	DT	O
method	method	NN	O
,	,	,	O
prognostic	prognostic	JJ	O
information	information	NN	O
can	can	MD	O
be	be	VB	O
obtained	obtain	VBN	O
in	in	IN	O
metastatic	metastatic	JJ	O
breast	breast	NN	O
,	,	,	O
colon	colon	NN	O
,	,	,	O
and	and	CC	O
prostate	prostate	NN	O
cancers	cancer	NNS	O
.	.	.	O

CTCsare	CTCsare	NNP	O
subjected	subject	VBD	O
to	to	IN	O
genomic	genomic	JJ	O
mapping	mapping	NN	B
,	,	,	O
allowing	allow	VBG	O
a	a	DT	O
detailed	detailed	JJ	O
analysis	analysis	NN	O
of	of	IN	O
the	the	DT	O
genes	gene	NNS	O
responsible	responsible	JJ	O
for	for	IN	O
the	the	DT	O
uncontrolled	uncontrolled	JJ	O
growth	growth	NN	O
of	of	IN	O
cells	cell	NNS	O
.	.	.	O

Of	of	RB	O
course	course	RB	O
,	,	,	O
the	the	DT	O
major	major	JJ	O
drawbacks	drawback	NNS	O
of	of	IN	O
this	this	DT	O
technique	technique	NN	O
are	be	VBP	O
to	to	TO	O
distinguish	distinguish	VB	O
cancer	cancer	NN	O
cells	cell	NNS	O
from	from	IN	O
millions	million	NNS	O
of	of	IN	O
healthy	healthy	JJ	O
cells	cell	NNS	O
;	;	:	O
the	the	DT	O
detection	detection	NN	O
of	of	IN	O
the	the	DT	O
kind	kind	NN	O
of	of	IN	O
cancer	cancer	NN	O
.	.	.	O

The	the	DT	O
presence	presence	NN	O
of	of	IN	O
ctDNA	ctdna	NN	O
in	in	IN	O
the	the	DT	O
blood	blood	NN	O
is	be	VBZ	O
dated	date	VBN	O
back	back	RB	O
in	in	IN	O
1948s	1948s	CD	B
.	.	.	O

Although	although	IN	O
circulating	circulate	VBG	O
cell	cell	NN	O
-	-	HYPH	O
tumour	tumour	NN	O
DNA	dna	NN	O
was	be	VBD	O
first	first	RB	O
identified	identify	VBN	O
in	in	IN	O
1948	1948	CD	O
,	,	,	O
it	-PRON-	PRP	O
has	have	VBZ	O
only	only	RB	O
recently	recently	RB	O
been	be	VBN	O
investigated	investigate	VBN	O
in	in	IN	O
âliquid	âliquid	NN	O
biopsyâ	biopsyâ	UH	O
as	as	IN	O
cancer	cancer	NN	O
biomarkers	biomarker	NNS	B
.	.	.	O

Tumours	tumour	NNS	O
release	release	VBP	O
fragments	fragment	NNS	O
of	of	IN	O
DNA	dna	NN	O
into	into	IN	O
the	the	DT	O
circulatory	circulatory	JJ	O
system	system	NN	O
,	,	,	O
which	which	WDT	O
are	be	VBP	O
detectable	detectable	JJ	O
and	and	CC	O
specific	specific	JJ	O
to	to	IN	O
cancer	cancer	NN	O
.	.	.	O

There	there	EX	O
are	be	VBP	O
several	several	JJ	O
advantages	advantage	NNS	O
to	to	IN	O
assessing	assess	VBG	O
ctDNA	ctdna	NN	O
.	.	.	O

Sampling	sampling	NN	O
is	be	VBZ	O
non	non	JJ	O
-	-	JJ	O
invasive	invasive	JJ	O
and	and	CC	O
inexpensive	inexpensive	JJ	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
tissue	tissue	NN	O
biopsy	biopsy	NN	O
.	.	.	O

Besides	besides	RB	O
,	,	,	O
ctDNA	ctdna	JJ	O
testing	testing	NN	O
can	can	MD	O
be	be	VB	O
easily	easily	RB	O
and	and	CC	O
frequently	frequently	RB	O
repeated	repeat	VBN	O
to	to	TO	O
monitor	monitor	VB	O
changes	change	NNS	O
that	that	WDT	O
occur	occur	VBP	O
during	during	IN	O
treatment	treatment	NN	O
,	,	,	O
serving	serve	VBG	O
as	as	IN	O
an	an	DT	O
early	early	JJ	O
indicator	indicator	NN	O
of	of	IN	O
recurrence	recurrence	NN	O
,	,	,	O
resistance	resistance	NN	O
,	,	,	O
or	or	CC	O
metastasis	metastasis	NN	B
.	.	.	O

Liquid	liquid	JJ	O
biopsy	biopsy	NN	O
is	be	VBZ	O
believed	believe	VBN	O
to	to	TO	O
exhibit	exhibit	VB	O
tumour	tumour	NN	O
heterogeneity	heterogeneity	NN	O
,	,	,	O
as	as	IN	O
cells	cell	NNS	O
circulate	circulate	VBP	O
from	from	IN	O
different	different	JJ	O
regions	region	NNS	O
of	of	IN	O
the	the	DT	O
tumour	tumour	NN	O
,	,	,	O
and	and	CC	O
to	to	TO	O
obtain	obtain	VB	O
information	information	NN	O
in	in	IN	O
a	a	DT	O
shorter	short	JJR	O
time	time	NN	B
.	.	.	O

CTCs	ctc	NNS	O
and	and	CC	O
ctDNAs	ctDNAs	NNP	O
derived	derive	VBN	O
from	from	IN	O
primary	primary	JJ	O
or	or	CC	O
metastatic	metastatic	JJ	O
cells	cell	NNS	O
are	be	VBP	O
abundant	abundant	JJ	O
in	in	IN	O
blood	blood	NN	O
.	.	.	O

Both	both	DT	O
CTC	CTC	NNP	O
and	and	CC	O
ctDNA	ctDNA	MD	O
provide	provide	VB	O
prognostic	prognostic	JJ	O
information	information	NN	O
based	base	VBN	O
on	on	IN	O
the	the	DT	O
number	number	NN	O
and	and	CC	O
level	level	NN	O
of	of	IN	O
events	event	NNS	O
detected	detect	VBD	B
.	.	.	O

Comparison	comparison	NN	O
of	of	IN	O
CTCs	ctc	NNS	O
and	and	CC	O
ctDNA	ctdna	NN	O
.	.	.	O

Allows	Allows	NNP	O
for	for	IN	O
DNA	DNA	NNP	O
,	,	,	O
RNA	RNA	NNP	O
,	,	,	O
protein	protein	NN	O
researchResearch	researchresearch	NN	O
at	at	IN	O
single	single	JJ	O
-	-	HYPH	O
cell	cell	NN	O
levelCaptured	levelcapture	VBN	O
cells	cell	NNS	O
can	can	MD	O
be	be	VB	O
used	use	VBN	O
for	for	IN	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
or	or	CC	O
inÂ	inÂ	NNP	O
vivo	vivo	NNP	O
studiesClinically	studiesclinically	RB	O
validated	validated	JJ	O
technology	technology	NN	O
available	available	JJ	O
Easily	easily	RB	O
isolated	isolate	VBN	O
with	with	IN	O
kitsCan	kitsCan	NNP	O
be	be	VB	O
stored	store	VBN	O
for	for	IN	O
a	a	DT	O
long	long	JJ	O
timeGives	timegive	NNS	O
more	more	RBR	O
precise	precise	JJ	O
resultsClinically	resultsclinically	RB	O
validated	validate	VBN	O
for	for	IN	O
EGFR	egfr	NN	O
mutations	mutation	NNS	O
in	in	IN	O
non	non	JJ	O
-	-	JJ	O
small	small	JJ	O
cell	cell	NN	O
lung	lung	NN	O
cancerA	cancerA	NNP	O
small	small	JJ	O
number	number	NN	O
of	of	IN	O
cells	cell	NNS	O
are	be	VBP	O
obtained	obtain	VBN	O
in	in	IN	O
non	non	JJ	O
-	-	JJ	O
metastatic	metastatic	JJ	O
conditionsCan	conditionsCan	NNS	O
not	not	RB	O
be	be	VB	O
stored	store	VBN	O
for	for	IN	O
a	a	DT	O
long	long	JJ	O
timeDetection	timedetection	NN	O
steps	step	NNS	O
are	be	VBP	O
expensivePrognostics	expensiveprognostic	NNS	O
and	and	CC	O
predictability	predictability	NN	O
are	be	VBP	O
unclearOnly	unclearonly	JJ	O
DNA	DNA	NNP	O
sequence	sequence	NN	O
analysis	analysis	NN	O
can	can	MD	O
be	be	VB	O
performedKnown	performedknown	JJ	O
target	target	NN	O
mutations	mutation	NNS	O
are	be	VBP	O
neededExtracellular	neededextracellular	JJ	O
Vesicles	vesicle	NNS	O
are	be	VBP	O
lipid	lipid	NN	O
structures	structure	NNS	O
released	release	VBN	O
from	from	IN	O
cells	cell	NNS	O
.	.	.	O

EVs	ev	NNS	O
contain	contain	VBP	O
proteins	protein	NNS	O
and	and	CC	O
nucleic	nucleic	JJ	O
acids	acid	NNS	O
and	and	CC	O
play	play	VB	O
a	a	DT	O
role	role	NN	O
in	in	IN	O
cellular	cellular	JJ	O
communication	communication	NN	O
,	,	,	O
immune	immune	JJ	O
regulation	regulation	NN	O
,	,	,	O
and	and	CC	O
microenvironmental	microenvironmental	JJ	O
modulation	modulation	NN	B
,	,	,	B
.	.	.	O

Nanosized	nanosize	VBN	O
exosomes	exosome	NNS	O
70â150ânm	70â150ânm	NN	O
are	be	VBP	O
the	the	DT	O
most	most	RBS	O
prominent	prominent	JJ	O
members	member	NNS	O
of	of	IN	O
these	these	DT	O
so	so	RB	O
-	-	HYPH	O
called	call	VBN	O
extracellular	extracellular	JJ	O
vesicles	vesicle	NNS	O
and	and	CC	O
are	be	VBP	O
released	release	VBN	O
from	from	IN	O
body	body	NN	O
fluids	fluid	NNS	O
such	such	JJ	O
as	as	IN	O
urine	urine	NN	O
,	,	,	O
ascites	ascite	NNS	O
,	,	,	O
and	and	CC	O
plasma	plasma	NN	B
,	,	,	B
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
they	-PRON-	PRP	O
are	be	VBP	O
liberated	liberate	VBN	O
over	over	IN	O
all	all	DT	O
kinds	kind	NNS	O
of	of	IN	O
body	body	NN	O
cells	cell	NNS	B
,	,	,	O
released	release	VBN	O
in	in	IN	O
almost	almost	RB	O
all	all	DT	O
cell	cell	NN	O
types	type	NNS	O
under	under	IN	O
physiological	physiological	JJ	O
and	and	CC	O
pathophysiological	pathophysiological	JJ	O
conditions	condition	NNS	O
and	and	CC	O
mediate	mediate	VB	O
intercellular	intercellular	JJ	O
contacts	contact	NNS	B
.	.	.	O

A	a	DT	O
theranostic	theranostic	JJ	O
solution	solution	NN	O
could	could	MD	O
be	be	VB	O
represented	represent	VBN	O
by	by	IN	O
the	the	DT	O
nanosized	nanosized	JJ	O
EVs	ev	NNS	O
,	,	,	O
which	which	WDT	O
may	may	MD	O
transmit	transmit	VB	O
biomarkers	biomarker	NNS	O
of	of	IN	O
diseases	disease	NNS	O
and/or	and/or	CC	O
vectors	vector	NNS	O
of	of	IN	O
therapeutic	therapeutic	JJ	O
molecules	molecule	NNS	O
,	,	,	O
offering	offer	VBG	O
a	a	DT	O
unique	unique	JJ	O
opportunity	opportunity	NN	O
to	to	TO	O
use	use	VB	O
a	a	DT	O
combination	combination	NN	O
of	of	IN	O
different	different	JJ	O
markers	marker	NNS	O
specifically	specifically	RB	O
expressed	express	VBN	O
for	for	IN	O
tumour	tumour	NN	O
-	-	HYPH	O
derived	derive	VBN	O
EVs	ev	NNS	B
,	,	,	B
,	,	,	B
.	.	.	O

For	for	IN	O
example	example	NN	O
,	,	,	O
Prostate	Prostate	NNP	O
-	-	HYPH	O
Specific	Specific	NNP	O
Antigen	Antigen	NNP	O
does	do	VBZ	O
not	not	RB	O
differentiate	differentiate	VB	O
between	between	IN	O
benign	benign	JJ	O
prostatic	prostatic	JJ	O
hyperplasia	hyperplasia	NNS	O
and	and	CC	O
a	a	DT	O
Prostate	Prostate	NNP	O
Cancer	Cancer	NNP	O
,	,	,	O
resulting	result	VBG	O
in	in	IN	O
large	large	JJ	O
numbers	number	NNS	O
of	of	IN	O
unnecessary	unnecessary	JJ	O
biopsies	biopsy	NNS	O
and	and	CC	O
missed	missed	JJ	O
diagnosis	diagnosis	NN	O
of	of	IN	O
cancer	cancer	NN	O
.	.	.	O

Since	since	IN	O
exosomes	exosome	NNS	O
are	be	VBP	O
directly	directly	RB	O
detectable	detectable	JJ	O
in	in	IN	O
patient	patient	JJ	O
plasma	plasma	NN	O
,	,	,	O
the	the	DT	O
plasmatic	plasmatic	JJ	O
exosomes	exosome	NNS	O
expressing	express	VBG	O
PSA	PSA	NNP	O
have	have	VBP	O
the	the	DT	O
potential	potential	NN	O
in	in	IN	O
distinguishing	distinguish	VBG	O
healthy	healthy	JJ	O
individuals	individual	NNS	O
,	,	,	O
BPH	BPH	NNP	O
,	,	,	O
and	and	CC	O
PC77	PC77	NNP	O
.	.	.	O

Recently	recently	RB	O
,	,	,	O
it	-PRON-	PRP	O
has	have	VBZ	O
been	be	VBN	O
demonstrated	demonstrate	VBN	O
that	that	IN	O
neurodegenerative	neurodegenerative	JJ	O
disorders	disorder	NNS	O
,	,	,	O
including	include	VBG	O
Alzheimerâs	alzheimerâs	CD	O
disease	disease	NN	O
,	,	,	O
Parkinson	Parkinson	NNP	O
,	,	,	O
and	and	CC	O
amyotrophic	amyotrophic	JJ	O
lateral	lateral	JJ	O
sclerosis	sclerosis	NN	O
,	,	,	O
are	be	VBP	O
correlated	correlate	VBN	O
with	with	IN	O
extracellular	extracellular	JJ	O
vesicles	vesicle	NNS	O
.	.	.	O

EVs	ev	NNS	O
have	have	VBP	O
also	also	RB	O
been	be	VBN	O
investigated	investigate	VBN	O
in	in	IN	O
relation	relation	NN	O
to	to	IN	O
infection	infection	NN	O
caused	cause	VBN	O
by	by	IN	O
viruses	virus	NNS	O
,	,	,	O
bacteria	bacteria	NNS	O
,	,	,	O
fungi	fungi	NN	O
,	,	,	O
protozoa	protozoa	NN	O
,	,	,	O
and	and	CC	O
helminths	helminth	NNS	B
.	.	.	O

Such	such	JJ	O
pathogens	pathogen	NNS	O
secrete	secrete	JJ	O
EVs	ev	NNS	O
,	,	,	O
and	and	CC	O
prions	prion	NNS	O
were	be	VBD	O
even	even	RB	O
present	present	JJ	O
in	in	IN	O
EVs	ev	NNS	O
.	.	.	O

Finally	finally	RB	O
,	,	,	O
EVs	ev	NNS	O
seem	seem	VBP	O
to	to	TO	O
play	play	VB	O
key	key	JJ	O
roles	role	NNS	O
in	in	IN	O
autoimmune	autoimmune	JJ	O
diseases	disease	NNS	B
.	.	.	O

EVs	ev	NNS	O
circulating	circulate	VBG	O
in	in	IN	O
body	body	NN	O
fluids	fluid	NNS	O
are	be	VBP	O
valuable	valuable	JJ	O
liquid	liquid	JJ	O
biopsy	biopsy	NN	O
biomarkers	biomarker	NNS	O
.	.	.	O

Additionally	additionally	RB	O
,	,	,	O
their	-PRON-	PRP$	O
protein	protein	NN	O
concentration	concentration	NN	O
is	be	VBZ	O
higher	high	JJR	O
in	in	IN	O
patients	patient	NNS	O
with	with	IN	O
advanced	advanced	JJ	O
tumours	tumour	NNS	B
.	.	.	O

The	the	DT	O
tumour	tumour	NN	O
-	-	HYPH	O
associated	associate	VBN	O
CA	CA	NNP	O
IX	IX	NNP	O
may	may	MD	O
be	be	VB	O
used	use	VBN	O
as	as	IN	O
a	a	DT	O
cancer	cancer	NN	O
biomarker	biomarker	NN	O
in	in	IN	O
the	the	DT	O
liquid	liquid	JJ	O
biopsy	biopsy	NN	O
technique	technique	NN	O
.	.	.	O

Carbonic	carbonic	JJ	O
anhydrase	anhydrase	VBP	O
IX	IX	NNP	O
is	be	VBZ	O
a	a	DT	O
transmembrane	transmembrane	JJ	O
enzyme	enzyme	NNS	B
,	,	,	O
and	and	CC	O
it	-PRON-	PRP	O
is	be	VBZ	O
involved	involve	VBN	O
in	in	IN	O
the	the	DT	O
growth	growth	NN	O
and	and	CC	O
development	development	NN	O
of	of	IN	O
tumour	tumour	NN	O
cell	cell	NN	O
adhesion	adhesion	NN	B
,	,	,	B
.	.	.	O

There	there	EX	O
is	be	VBZ	O
an	an	DT	O
association	association	NN	O
between	between	IN	O
elevated	elevated	JJ	O
serum	serum	NN	O
levels	level	NNS	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
and	and	CC	O
CTCs	ctc	NNS	B
.	.	.	O

This	this	DT	O
suggests	suggest	VBZ	O
a	a	DT	O
relationship	relationship	NN	O
between	between	IN	O
hypoxia	hypoxia	NNP	O
and	and	CC	O
tumour	tumour	NN	O
cell	cell	NN	O
circulation	circulation	NN	O
in	in	IN	O
the	the	DT	O
bloodstream	bloodstream	NN	O
.	.	.	O

In	in	IN	O
the	the	DT	O
peripheral	peripheral	JJ	O
venous	venous	JJ	O
blood	blood	NN	O
,	,	,	O
it	-PRON-	PRP	O
is	be	VBZ	O
also	also	RB	O
possible	possible	JJ	O
to	to	TO	O
find	find	VB	O
the	the	DT	O
soluble	soluble	JJ	O
form	form	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
released	release	VBN	O
by	by	IN	O
proteolytic	proteolytic	JJ	O
cleavage	cleavage	NN	B
,	,	,	B
,	,	,	B
.	.	.	O

For	for	IN	O
example	example	NN	O
,	,	,	O
a	a	DT	O
high	high	JJ	O
level	level	NN	O
of	of	IN	O
soluble	soluble	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
was	be	VBD	O
found	find	VBN	O
in	in	IN	O
the	the	DT	O
serum	serum	NN	O
of	of	IN	O
patients	patient	NNS	O
with	with	IN	O
renal	renal	JJ	O
cancer	cancer	NN	B
.	.	.	O

MÃ¼ller	MÃ¼ller	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	NNP	O

investigated	investigate	VBD	O
the	the	DT	O
relationship	relationship	NN	O
between	between	IN	O
serum	serum	NN	O
levels	level	NNS	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
and	and	CC	O
CTCs	ctc	NNS	O
in	in	IN	O
metastatic	metastatic	JJ	O
breast	breast	NN	O
cancer	cancer	NN	B
.	.	.	O

Their	-PRON-	PRP$	O
findings	finding	NNS	O
suggested	suggest	VBD	O
that	that	IN	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
activity	activity	NN	O
level	level	NN	O
was	be	VBD	O
higher	high	JJR	O
in	in	IN	O
cancer	cancer	NN	O
types	type	NNS	O
with	with	IN	O
a	a	DT	O
high	high	JJ	O
number	number	NN	O
of	of	IN	O
CTCs	ctc	NNS	O
.	.	.	O

In	in	IN	O
this	this	DT	O
condition	condition	NN	O
,	,	,	O
it	-PRON-	PRP	O
is	be	VBZ	O
expected	expect	VBN	O
a	a	DT	O
decrease	decrease	NN	O
in	in	IN	O
the	the	DT	O
patientâs	patientâs	CD	O
overall	overall	JJ	O
survival	survival	NN	O
.	.	.	O

Besides	besides	RB	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
disrupts	disrupt	VBZ	O
cell	cell	NN	O
-	-	HYPH	O
cell	cell	NN	O
and	and	CC	O
cell	cell	NN	O
-	-	HYPH	O
matrix	matrix	NN	O
interactions	interaction	NNS	O
by	by	IN	O
triggering	trigger	VBG	O
tumour	tumour	NN	O
acidification	acidification	NN	O
.	.	.	O

As	as	IN	O
a	a	DT	O
consequence	consequence	NN	O
,	,	,	O
CTCs	ctc	NNS	O
separate	separate	JJ	O
from	from	IN	O
the	the	DT	O
primary	primary	JJ	O
tumour	tumour	NN	O
,	,	,	O
and	and	CC	O
invasion	invasion	NN	O
occurs	occur	VBZ	O
.	.	.	O

Probably	probably	RB	O
,	,	,	O
CA	CA	NNP	O
IX	ix	NN	O
inhibition	inhibition	NN	O
could	could	MD	O
slow	slow	VB	O
down	down	RP	O
the	the	DT	O
invasion	invasion	NN	O
process	process	NN	O
of	of	IN	O
CTCs	ctc	NNS	O
.	.	.	O

During	during	IN	O
the	the	DT	O
tumour	tumour	NN	O
progression	progression	NN	O
,	,	,	O
exosomes	exosome	NNS	O
and	and	CC	O
the	the	DT	O
metalloenzyme	metalloenzyme	NNS	O
CA	CA	NNP	O
IX	IX	NNP	O
affect	affect	VBP	O
the	the	DT	O
growth	growth	NN	O
and	and	CC	O
proliferation	proliferation	NN	O
of	of	IN	O
the	the	DT	O
tumour	tumour	NN	O
.	.	.	O

The	the	DT	O
relationship	relationship	NN	O
between	between	IN	O
exosomes	exosome	NNS	O
and	and	CC	O
CA	CA	NNP	O
IX	IX	NNP	O
has	have	VBZ	O
been	be	VBN	O
investigated	investigate	VBN	O
using	use	VBG	O
an	an	DT	O
inÂ	inÂ	NNP	O
vitro	vitro	FW	O
cellular	cellular	JJ	O
model	model	NN	O
of	of	IN	O
human	human	JJ	O
prostate	prostate	NN	O
carcinoma	carcinoma	NN	O
cell	cell	NN	O
line	line	NN	O
cultured	culture	VBN	O
in	in	IN	O
different	different	JJ	O
pH	ph	NN	O
conditions	condition	NNS	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
showed	show	VBD	O
that	that	IN	O
the	the	DT	O
acidic	acidic	JJ	O
microenvironment	microenvironment	NN	O
increased	increase	VBD	O
both	both	CC	O
the	the	DT	O
expression	expression	NN	O
and	and	CC	O
activity	activity	NN	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
in	in	IN	O
cancer	cancer	NN	O
cells	cell	NNS	B
.	.	.	O

Besides	besides	RB	O
,	,	,	O
the	the	DT	O
number	number	NN	O
of	of	IN	O
exosomes	exosome	NNS	O
released	release	VBN	O
by	by	IN	O
the	the	DT	O
cancer	cancer	NN	O
cells	cell	NNS	O
was	be	VBD	O
raised	raise	VBN	O
together	together	RB	O
with	with	IN	O
the	the	DT	O
upregulation	upregulation	NN	O
of	of	IN	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	B
.	.	.	O

These	these	DT	O
data	datum	NNS	O
strongly	strongly	RB	O
support	support	VBP	O
that	that	WDT	O
exosomes	exosome	VBZ	O
and	and	CC	O
CA	CA	NNP	O
IX	IX	NNP	O
are	be	VBP	O
tumour	tumour	NN	O
-	-	HYPH	O
associated	associate	VBN	O
components	component	NNS	O
and	and	CC	O
the	the	DT	O
enzyme	enzyme	NNS	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
a	a	DT	O
cancer	cancer	NN	O
biomarker	biomarker	NN	O
that	that	WDT	O
could	could	MD	O
be	be	VB	O
used	use	VBN	O
as	as	IN	O
valuable	valuable	JJ	O
target	target	NN	O
of	of	IN	O
the	the	DT	O
liquid	liquid	JJ	O
biopsy	biopsy	NN	B
.	.	.	O

Horie	Horie	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	NNP	O

demonstrated	demonstrate	VBD	O
that	that	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
exosomes	exosome	NNS	O
were	be	VBD	O
released	release	VBN	O
from	from	IN	O
renal	renal	JJ	O
carcinoma	carcinoma	NN	O
cells	cell	NNS	B
.	.	.	O

The	the	DT	O
quantity	quantity	NN	O
of	of	IN	O
exosomal	exosomal	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
increased	increase	VBN	O
in	in	IN	O
hypoxia	hypoxia	NNP	O
response	response	NN	O
,	,	,	O
promoting	promote	VBG	O
upregulation	upregulation	NN	O
of	of	IN	O
MMP-2	MMP-2	NNP	O
,	,	,	O
migration	migration	NN	O
and	and	CC	O
tube	tube	NN	O
formation	formation	NN	O
,	,	,	O
and	and	CC	O
may	may	MD	O
induce	induce	VB	O
angiogenesis	angiogenesis	NN	O
in	in	IN	O
the	the	DT	O
tumour	tumour	NN	O
microenvironment	microenvironment	NN	B
.	.	.	O

Dorai	Dorai	NNP	O
and	and	CC	O
co	co	NNS	O
-	-	NNS	O
workers	worker	NNS	O
analysed	analyse	VBD	O
the	the	DT	O
effect	effect	NN	O
of	of	IN	O
increasing	increase	VBG	O
expression	expression	NN	O
levels	level	NNS	O
of	of	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
in	in	IN	O
renal	renal	JJ	O
cancer	cancer	NN	O
cells	cell	NNS	O
.	.	.	O

They	-PRON-	PRP	O
showed	show	VBD	O
that	that	IN	O
the	the	DT	O
level	level	NN	O
of	of	IN	O
released	release	VBN	O
gangliocytes	gangliocyte	NNS	O
was	be	VBD	O
positively	positively	RB	O
correlated	correlate	VBN	O
to	to	IN	O
that	that	DT	O
of	of	IN	O
exosomal	exosomal	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	B
.	.	.	O

Gangliosides	ganglioside	NNS	O
play	play	VBP	O
a	a	DT	O
critical	critical	JJ	O
role	role	NN	O
in	in	IN	O
cell	cell	NN	O
adhesion	adhesion	NN	O
,	,	,	O
migration	migration	NN	O
,	,	,	O
and	and	CC	O
cell	cell	NN	O
signalling	signal	VBG	B
.	.	.	O

Since	since	IN	O
CA	CA	NNP	O
IX	IX	NNP	O
induces	induce	VBZ	O
the	the	DT	O
release	release	NN	O
of	of	IN	O
gangliocyte	gangliocyte	NN	O
-	-	HYPH	O
containing	contain	VBG	O
exosomes	exosome	NNS	O
,	,	,	O
the	the	DT	O
exosomal	exosomal	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
may	may	MD	O
be	be	VB	O
a	a	DT	O
valuable	valuable	JJ	O
biomarker	biomarker	NN	O
of	of	IN	O
the	the	DT	O
carcinogenesis	carcinogenesis	NN	O
process	process	NN	O
.	.	.	O

CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
is	be	VBZ	O
regulated	regulate	VBN	O
exclusively	exclusively	RB	O
by	by	IN	O
HIF-1Î±	HIF-1Î±	NNS	O
,	,	,	O
rapidly	rapidly	RB	O
increases	increase	VBZ	O
in	in	IN	O
response	response	NN	O
to	to	IN	O
hypoxia	hypoxia	NNP	O
,	,	,	O
and	and	CC	O
is	be	VBZ	O
very	very	RB	O
important	important	JJ	O
for	for	IN	O
maintaining	maintain	VBG	O
the	the	DT	O
acidic	acidic	JJ	O
pH	pH	NNP	O
of	of	IN	O
the	the	DT	O
tumor	tumor	NN	B
.	.	.	O

Brown	Brown	NNP	O
-	-	HYPH	O
Glaberman	Glaberman	NNP	O
proposed	propose	VBD	O
that	that	IN	O
the	the	DT	O
circulating	circulate	VBG	O
CA	CA	NNP	O
IX	IX	NNP	O
could	could	MD	O
be	be	VB	O
considered	consider	VBN	O
as	as	IN	O
a	a	DT	O
biomarker	biomarker	NN	O
for	for	IN	O
detecting	detect	VBG	O
the	the	DT	O
level	level	NN	O
of	of	IN	O
hypoxia	hypoxia	NNP	O
and	and	CC	O
the	the	DT	O
upregulation	upregulation	NN	O
of	of	IN	O
HIF-1Î±	HIF-1Î±	NNP	B
,	,	,	B
.	.	.	O

Circulating	circulate	VBG	O
CA	CA	NNP	O
IX	IX	NNP	O
can	can	MD	O
be	be	VB	O
easily	easily	RB	O
isolated	isolate	VBN	O
from	from	IN	O
body	body	NN	O
fluids	fluid	NNS	O
and	and	CC	O
considered	consider	VBD	O
a	a	DT	O
biomarker	biomarker	NN	O
for	for	IN	O
different	different	JJ	O
stages	stage	NNS	O
of	of	IN	O
cancers	cancer	NNS	O
and	and	CC	O
the	the	DT	O
differentiation	differentiation	NN	O
of	of	IN	O
local	local	JJ	O
/	/	SYM	O
advanced	advanced	JJ	O
tumours	tumour	NNS	O
.	.	.	O

Malentacchi	Malentacchi	NNP	O
and	and	CC	O
coworkers	coworker	NNS	O
to	to	TO	O
validate	validate	VB	O
circulating	circulate	VBG	O
CA	CA	NNP	O
IX	IX	NNP	O
as	as	IN	O
a	a	DT	O
tumour	tumour	NN	O
biomarker	biomarker	NN	O
measuring	measure	VBG	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
mRNA	mrna	NN	O
in	in	IN	O
the	the	DT	O
urine	urine	NN	O
sediments	sediment	NNS	O
of	of	IN	O
patients	patient	NNS	O
affected	affect	VBN	O
by	by	IN	O
kidney	kidney	NN	O
,	,	,	O
prostate	prostate	NN	O
,	,	,	O
and	and	CC	O
bladder	bladder	NN	O
cancers	cancer	NNS	B
.	.	.	O

As	as	IN	O
a	a	DT	O
result	result	NN	O
,	,	,	O
they	-PRON-	PRP	O
associated	associate	VBD	O
the	the	DT	O
mRNACA	mRNACA	NNS	O
IX	IX	NNP	O
expression	expression	NN	O
in	in	IN	O
the	the	DT	O
tumour	tumour	NN	O
of	of	IN	O
urogenital	urogenital	JJ	O
origin	origin	NN	O
.	.	.	O

Liu	Liu	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	NNP	O

have	have	VBP	O
found	find	VBN	O
that	that	IN	O
the	the	DT	O
combination	combination	NN	O
of	of	IN	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
/	/	SYM	O
CD147	CD147	NNP	O
antibodies	antibody	NNS	O
achieved	achieve	VBD	O
higher	high	JJR	O
efficiency	efficiency	NN	O
in	in	IN	O
the	the	DT	O
NanoVelcro	NanoVelcro	NNP	O
platform	platform	NN	O
compared	compare	VBN	O
to	to	IN	O
EPCAM	EPCAM	NNP	O
-	-	HYPH	O
based	base	VBN	O
methods	method	NNS	O
for	for	IN	O
capturing	capture	VBG	O
circulating	circulate	VBG	O
cells	cell	NNS	O
coming	come	VBG	O
from	from	IN	O
the	the	DT	O
renal	renal	JJ	O
carcinoma	carcinoma	NN	B
.	.	.	O

Liquid	liquid	JJ	O
biopsy	biopsy	NN	O
technology	technology	NN	O
allows	allow	VBZ	O
the	the	DT	O
detection	detection	NN	O
of	of	IN	O
solid	solid	JJ	O
tumours	tumour	NNS	O
,	,	,	O
such	such	JJ	O
as	as	IN	O
those	those	DT	O
involving	involve	VBG	O
lung	lung	NN	O
,	,	,	O
breast	breast	NN	O
,	,	,	O
and	and	CC	O
pancreatic	pancreatic	JJ	O
,	,	,	O
using	use	VBG	O
the	the	DT	O
blood	blood	NN	O
or	or	CC	O
other	other	JJ	O
body	body	NN	O
fluids	fluid	NNS	O
.	.	.	O

Liquid	liquid	JJ	O
biopsy	biopsy	NN	O
can	can	MD	O
detect	detect	VB	O
cancer	cancer	NN	O
-	-	HYPH	O
specific	specific	JJ	O
markers	marker	NNS	O
even	even	RB	O
in	in	IN	O
lesions	lesion	NNS	O
that	that	WDT	O
are	be	VBP	O
too	too	RB	O
small	small	JJ	O
to	to	TO	O
be	be	VB	O
recognised	recognise	VBN	O
by	by	IN	O
other	other	JJ	O
available	available	JJ	O
methods	method	NNS	O
,	,	,	O
indicating	indicate	VBG	O
that	that	IN	O
this	this	DT	O
method	method	NN	O
can	can	MD	O
be	be	VB	O
used	use	VBN	O
early	early	RB	O
in	in	IN	O
cancer	cancer	NN	O
diagnosis	diagnosis	NN	O
.	.	.	O

Among	among	IN	O
the	the	DT	O
known	know	VBN	O
biomarkers	biomarker	NNS	O
of	of	IN	O
the	the	DT	O
liquid	liquid	JJ	O
biopsy	biopsy	NN	O
,	,	,	O
the	the	DT	O
CA	CA	NNP	O
IXisoenzyme	IXisoenzyme	NNPS	O
could	could	MD	O
be	be	VB	O
a	a	DT	O
promising	promising	JJ	O
candidate	candidate	NN	O
for	for	IN	O
tumour	tumour	NN	O
detection	detection	NN	O
.	.	.	O

In	in	IN	O
fact	fact	NN	O
,	,	,	O
the	the	DT	O
CA	CA	NNP	O
IX	IX	NNP	O
activity	activity	NN	O
level	level	NN	O
is	be	VBZ	O
higher	high	JJR	O
in	in	IN	O
cancer	cancer	NN	O
types	type	NNS	O
with	with	IN	O
a	a	DT	O
high	high	JJ	O
number	number	NN	O
of	of	IN	O
CTCs	ctc	NNS	O
;	;	:	O
the	the	DT	O
quantity	quantity	NN	O
of	of	IN	O
exosomal	exosomal	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
increased	increase	VBN	O
in	in	IN	O
hypoxia	hypoxia	NNP	O
response	response	NN	O
;	;	:	O
the	the	DT	O
release	release	NN	O
of	of	IN	O
the	the	DT	O
exosomal	exosomal	JJ	O
gangliocyte	gangliocyte	NN	O
is	be	VBZ	O
correlated	correlate	VBN	O
to	to	IN	O
the	the	DT	O
exosomal	exosomal	JJ	O
CA	CA	NNP	O
IX	IX	NNP	O
expression	expression	NN	O
increase	increase	NN	O
;	;	:	O
the	the	DT	O
circulating	circulate	VBG	O
CA	CA	NNP	O
IX	IX	NNP	O
is	be	VBZ	O
associated	associate	VBN	O
to	to	IN	O
tumors	tumor	NNS	O
of	of	IN	O
urogenital	urogenital	JJ	O
origin	origin	NN	O
;	;	:	O
CA	CA	NNP	O
IX	IX	NNP	O
disrupts	disrupt	VBZ	O
cell	cell	NN	O
-	-	HYPH	O
cell	cell	NN	O
and	and	CC	O
cell	cell	NN	O
-	-	HYPH	O
matrix	matrix	NN	O
interactions	interaction	NNS	O
by	by	IN	O
triggering	trigger	VBG	O
tumour	tumour	NN	O
acidification	acidification	NN	O
.	.	.	O

In	in	IN	O
this	this	DT	O
context	context	NN	O
,	,	,	O
the	the	DT	O
tumour	tumour	NN	O
-	-	HYPH	O
associated	associate	VBN	O
CA	CA	NNP	O
IX	IX	NNP	O
could	could	MD	O
be	be	VB	O
considered	consider	VBN	O
a	a	DT	O
valid	valid	JJ	O
biomarker	biomarker	NN	O
of	of	IN	O
the	the	DT	O
non	non	JJ	O
-	-	JJ	O
invasive	invasive	JJ	O
liquid	liquid	NN	O
biopsy	biopsy	NN	O
,	,	,	O
which	which	WDT	O
is	be	VBZ	O
viewed	view	VBN	O
as	as	IN	O
a	a	DT	O
technique	technique	NN	O
that	that	WDT	O
offers	offer	VBZ	O
future	future	JJ	O
research	research	NN	O
on	on	IN	O
precision	precision	NN	O
diagnosis	diagnosis	NN	O
and	and	CC	O
treatment	treatment	NN	O
of	of	IN	O
tumours	tumour	NNS	O
in	in	IN	O
a	a	DT	O
non	non	JJ	O
-	-	JJ	O
invasive	invasive	JJ	O
manner	manner	NN	O
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
CA	CA	NNP	O
IX	IX	NNP	O
could	could	MD	O
be	be	VB	O
a	a	DT	O
valid	valid	JJ	O
molecular	molecular	JJ	O
target	target	NN	O
in	in	IN	O
the	the	DT	O
treatment	treatment	NN	O
of	of	IN	O
cancer	cancer	NN	O
.	.	.	O

